Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shares OS slightly decreased from 4/18/07?

Shares OS slightly decreased from 4/18/07?

posted on Aug 17, 2007 10:52AM

Agora says that 390,092,696 shares were outstanding on 4/18.

The 10K says that there were  393,201,134 OS on 5/31 

*Subsequently we repurchased 4,961,640 shares and issued 1,150,000 shares through option and warrant conversions for a net reduction of 3,811,640 shares.

 393,201,134 minus  3,811,640 =  389,389,494 assumed OS. Assuming that no non S&L warrants have been converted.

I think someone said that the repurchase of S&L warrants will not have an effect on OS. We could be very close to the end of share dilution.

 

*Subsequent events (10K)

During the period June 1, 2007 through August 1, 2007, we purchased 4,961,640 shares of our common stock at an aggregate cost of $2,725,793 pursuant to our stock buyback program.

On July 5, 2007, we received proceeds of $6,250 from the issuance of 125,000 shares of common stock in connection with the exercise of warrants.

 

On August 6, 2007, our former chief executive officer exercised 1,000,000 of the 1,500,000 options granted to him in June 2006. The options were exercised utilizing a full payment in shares method within the grant and in accordance with the provisions of the payment in shares method, the officer received 656,250 new shares of stock.

 

On August 7, 2007 we received proceeds of $1,750 from a director who exercised 25,000 stock options.

Share
New Message
Please login to post a reply